We ran our own APOE4 photobiomodulation study. Here's the data.
60+ carriers, 4 months: Real-world data is messy. We tracked all of it. Here's what moved.
Key takeaways · TL;DR
60+ carriers, 4 months: Real-world data is messy. We tracked all of it. Here's what moved.
Hi Phoenix friend,
Here's the question almost nobody answers honestly:
When a prevention intervention "works" in a clinical trial, does it actually hold up in real life? In real people? Over real months, not lab conditions?
You know why this one matters to me. As an APOE4/4 carrier, I don't have decades to wait for the literature to catch up. Neither do you. Our brains are changing now.
So we stopped waiting and ran our own study.
Our study with Neuronic
From December 2025 through April 2026, we partnered with Neuronic to run a 4-month, real-world photobiomodulation study — near-infrared light therapy for the brain. More than 60 participants took part.
This was our study, on our platform. It wasn't a survey — every participant tracked their data through Phoenix:
Device usage logs
Daily check-ins
Sleep records
HRV
Blood biomarkers
Full supplement and lifestyle context
That last point is the whole game. Real-world data is messy — people travel, sleep badly, swap supplements, miss sessions. Most studies quietly bury that. We captured it, so we could actually see what moved the needle and what didn't.
What I'll show you on June 4
I'm presenting the full results live, alongside Neuronic's data analyst, who ran the formal statistics. Together we'll cover:
What the data actually showed
Where our methodology fell short — yes, I'll show you the cracks
What these signals mean for designing better real-world prevention research
No spin. No cherry-picking. The wins and the warts — because that's the only kind of science I'd trust with my own brain.
How our members got involved
When we launched this study, Phoenix members got the Neuronic device at a $695 discount (essentially the cost price of making the device) plus a 90-day satisfaction guarantee. Real device, real data, no risk.
That's what being inside the community unlocks: not just access to studies like this, but access on terms you won't find anywhere else.
Want in on the next one?
This was one study. We're building a pipeline of them — APOE4-specific research you literally can't join anywhere else, because no one else has a community of carriers tracking their data together.
If you want first access to the next study, join The Phoenix Community →
🗓 Event details
Beyond the RCT: Real-World Photobiomodulation Data in APOE4 Carriers
Our study with Neuronic
Thursday, June 4, 2026
8:00 AM PDT · 11:00 AM EDT · 11:00 PM SGT (~60 min)
Join free: https://us06web.zoom.us/j/83989866219
Can't make it live? Register anyway — we'll send you the replay.
See you Thursday.
— Kevin (APOE4/4, founder of Phoenix)
